Cargando…

Pan-Cancer Analysis of the Immunological Role of PDIA5: A Potential Target for Immunotherapy

The aberrant protein disulfide isomerase A5 (PDIA5) expression was relevant to the poor prognosis of patients with human cancers. However, its relationship with the epigenetic and genetic alterations and its effect on tumor immunity is still lacking. In the present study, we comprehensively analyzed...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Yu, He, Jialin, Chen, Rui, Wang, Zeyu, Dai, Ziyu, Liang, Xisong, Wu, Wantao, Luo, Peng, Zhang, Jian, Peng, Yun, Zhang, Nan, Liu, Zaoqu, Zhang, Liyang, Zhang, Hao, Cheng, Quan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9393377/ https://www.ncbi.nlm.nih.gov/pubmed/36003400 http://dx.doi.org/10.3389/fimmu.2022.881722

Ejemplares similares

PDIA5 is Correlated With Immune Infiltration and Predicts Poor Prognosis in Gliomas
por: Zhang, Hao, et al.
Publicado: (2021)

A pan-cancer and single-cell sequencing analysis of CD161, a promising onco-immunological biomarker in tumor microenvironment and immunotherapy
por: Li, He, et al.
Publicado: (2022)

Antigen Presentation Machinery Signature-Derived CALR Mediates Migration, Polarization of Macrophages in Glioma and Predicts Immunotherapy Response
por: Chen, Rui, et al.
Publicado: (2022)

Corrigendum: Antigen Presentation Machinery Signature-Derived CALR Mediates Migration, Polarization of Macrophages in Glioma and Predicts Immunotherapy Response
por: Chen, Rui, et al.
Publicado: (2022)

JMJD8 Is an M2 Macrophage Biomarker, and It Associates With DNA Damage Repair to Facilitate Stemness Maintenance, Chemoresistance, and Immunosuppression in Pan-Cancer
por: Liang, Xisong, et al.
Publicado: (2022)

Identify the immune characteristics and immunotherapy value of CD93 in the pan-cancer based on the public data sets
por: Guo, Aiyuan, et al.
Publicado: (2022)

Large-Scale Single-Cell and Bulk Sequencing Analyses Reveal the Prognostic Value and Immune Aspects of CD147 in Pan-Cancer
por: Zhang, Jingwei, et al.
Publicado: (2022)

Immunogenic cell death related risk model to delineate ferroptosis pathway and predict immunotherapy response of patients with GBM
por: Feng, Songshan, et al.
Publicado: (2022)

The Comprehensive Analysis Identified an Autophagy Signature for the Prognosis and the Immunotherapy Efficiency Prediction in Lung Adenocarcinoma
por: Li, Xizhe, et al.
Publicado: (2022)

Pericyte mediates the infiltration, migration, and polarization of macrophages by CD163/MCAM axis in glioblastoma
por: Zhang, Hao, et al.
Publicado: (2022)

Tumor-secreted lactate contributes to an immunosuppressive microenvironment and affects CD8 T-cell infiltration in glioblastoma
por: Wang, Zeyu, et al.
Publicado: (2023)

Machine learning-based identification of SOX10 as an immune regulator of macrophage in gliomas
por: Xiao, Gelei, et al.
Publicado: (2022)

Hyaluronic acids mediate the infiltration, migration, and M2 polarization of macrophages: evaluating metabolic molecular phenotypes in gliomas
por: Zhang, Hao, et al.
Publicado: (2022)

A Pan-Cancer Analysis Reveals CLEC5A as a Biomarker for Cancer Immunity and Prognosis
por: Chen, Rui, et al.
Publicado: (2022)

Machine learning-based identification of tumor-infiltrating immune cell-associated lncRNAs for improving outcomes and immunotherapy responses in patients with low-grade glioma
por: Zhang, Nan, et al.
Publicado: (2022)

Large-scale bulk RNA-seq analysis defines immune evasion mechanism related to mast cell in gliomas
por: Chen, Rui, et al.
Publicado: (2022)

Glioblastoma glycolytic signature predicts unfavorable prognosis, immunological heterogeneity, and ENO1 promotes microglia M2 polarization and cancer cell malignancy
por: Liang, Xisong, et al.
Publicado: (2022)

An artificial intelligence network‐guided signature for predicting outcome and immunotherapy response in lung adenocarcinoma patients based on 26 machine learning algorithms
por: Zhang, Nan, et al.
Publicado: (2023)

RUNX1/CD44 axis regulates the proliferation, migration, and immunotherapy of gliomas: A single-cell sequencing analysis
por: Zhang, Hao, et al.
Publicado: (2023)

Identify the Prognostic and Immune Profile of VSIR in the Tumor Microenvironment: A Pan-Cancer Analysis
por: Liu, Yuanyuan, et al.
Publicado: (2022)

Comprehensive analysis of pyroptosis‐related gene signatures for glioblastoma immune microenvironment and target therapy
por: Wang, Zeyu, et al.
Publicado: (2023)

Novel Immune Infiltrating Cell Signature Based on Cell Pair Algorithm Is a Prognostic Marker in Cancer
por: Zhang, Hao, et al.
Publicado: (2021)

Pan-Cancer Analysis of PDIA3: Identifying It as a Potential Biomarker for Tumor Prognosis and Immunotherapy
por: Zhang, Jing, et al.
Publicado: (2022)

PDIA3 correlates with clinical malignant features and immune signature in human gliomas
por: Zhang, Hao, et al.
Publicado: (2020)

The Predictive Value of Monocytes in Immune Microenvironment and Prognosis of Glioma Patients Based on Machine Learning
por: Zhang, Nan, et al.
Publicado: (2021)

Immune Infiltrating Cells-Derived Risk Signature Based on Large-scale Analysis Defines Immune Landscape and Predicts Immunotherapy Responses in Glioma Tumor Microenvironment
por: Zhang, Nan, et al.
Publicado: (2021)

TNFSF13 Is a Novel Onco-Inflammatory Marker and Correlates With Immune Infiltration in Gliomas
por: Chen, Rui, et al.
Publicado: (2021)

Identification of a Hypoxia-Angiogenesis lncRNA Signature Participating in Immunosuppression in Gastric Cancer
por: Wang, Zicheng, et al.
Publicado: (2022)

Immune checkpoint modulators in cancer immunotherapy: recent advances and emerging concepts
por: Wang, Yuchen, et al.
Publicado: (2022)

The ALDH Family Contributes to Immunocyte Infiltration, Proliferation and Epithelial-Mesenchymal Transformation in Glioma
por: Wang, Zeyu, et al.
Publicado: (2022)

Ferroptosis Activation Scoring Model Assists in Chemotherapeutic Agents’ Selection and Mediates Cross-Talk With Immunocytes in Malignant Glioblastoma
por: Wang, Zeyu, et al.
Publicado: (2022)

GPC2 Is a Potential Diagnostic, Immunological, and Prognostic Biomarker in Pan-Cancer
por: Chen, Guoming, et al.
Publicado: (2022)

Systematic Pan-Cancer Analysis Identifies TREM2 as an Immunological and Prognostic Biomarker
por: Cheng, Xin, et al.
Publicado: (2021)

Regulatory mechanisms of immune checkpoints PD-L1 and CTLA-4 in cancer
por: Zhang, Hao, et al.
Publicado: (2021)

Immune Characteristics of LYN in Tumor Microenvironment of Gliomas
por: Jiang, Chonghua, et al.
Publicado: (2022)

Define cancer-associated fibroblasts (CAFs) in the tumor microenvironment: new opportunities in cancer immunotherapy and advances in clinical trials
por: Zhang, Hao, et al.
Publicado: (2023)

GPX8 regulates pan-apoptosis in gliomas to promote microglial migration and mediate immunotherapy responses
por: Chen, Zigui, et al.
Publicado: (2023)

Glioma targeted therapy: insight into future of molecular approaches
por: Yang, Keyang, et al.
Publicado: (2022)

The molecular feature of macrophages in tumor immune microenvironment of glioma patients
por: Zhang, Hao, et al.
Publicado: (2021)

Insights Into the Prognostic Value and Immunological Role of NAAA in Pan-Cancer
por: Huang, Da, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_bbt1ncrrqh65hpp42414bj5pqd